跳至主要内容
临床试验/CTRI/2024/09/073241
CTRI/2024/09/073241尚未招募不适用

Effectiveness and Safety of Segmental Thoracic Spinal Anaesthesia using Isobaric Levobupivacaine 0.5 percent versus Hyperbaric Levobupivacaine 0.5 percent in Laproscopic Cholecystectomy

GSVM1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年9月14日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Efficacy of Sensory and Motor Block

研究概览

简要总结

Laparoscopic procedures like lap cholecystectomy has become a day care procedure due to advancement in surgical as well as anaesthesia technique.To compare isobaric levobupivacaine 0.5 % with hyperbaric levobupivacaine 0.5% in segmental thoracic spinal anaesthesia in laparoscopic cholecystectomy:- Primary aim: Effective sensory block ( onset and duration),Effective motor block ( onset and duration),  Hemodynamic stability AND Secondary aim Adverse effects if any( incidence of shoulder pain). 30 patients will be selected randomly for laparoscopic cholecystectomy in group A and  group B. Written informed consent to be taken. consent to be taken regarding discomfort, pain during surgery, immediate intervention will be done( general anaesthesia  may be supplemented).

Technique:

a)       After securing intravenous line and standard ASA monitoring,  premedication given.

b)      Painting and draping done adequately.

c)       Locate T10-T11 interspace after identifying T7 corresponding to inferior angle of scapula. After giving local anaesthesia , spinal anaethesia given with 25 G quinke needle after confirmation of CSF.

d)      No tilting of table will be done.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Informed written consent 2) Age: 18- 60 yrs 3) American society of anaestheslogist (ASA) I and II 4) Elective surgery 5) Duration of surgery not exceeding 90 min.

排除标准

  • 未提供

结局指标

主要结局

Efficacy of Sensory and Motor Block

时间窗: Onset and Duration of sensory block | Onset and Duration of motor block

次要结局

  • Hemodynamic Variables(Adverse effects)

研究者

发起方
GSVM
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

dr Neha Mishra

GSVM MEDICAL COLLEGE, KANPUR

研究点 (1)

Loading locations...

相似试验